每年專案
個人檔案
學歷
- 2014-2020 臺北醫學大學轉譯醫學博士學位學程博士
- 2000-2007 臺北醫學大學醫學系學士
經歷
- 2024.08- 臺北醫學大學醫學系放射線學科副教授
- 臺北醫學大學附設醫院專任主治醫師
- 2021.01- 臺北醫學大學附設醫院放射腫瘤科主任
- 2020.11- 臺北醫學大學醫學系放射線學科助理教授
- 2019.08-2020.12 臺北醫學大學附設醫院放射腫瘤科代主任
- 2014.04-2015.06 臺北醫學大學附設醫院兼任主治醫師
- 2013.04-2014.09 壢新醫院兼任主治醫師
- 2012.11-2015.06 臺北市立萬芳醫院專任主治醫師
指紋
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
-
探索奈米劑型球薑酮在頭頸癌質子放射治療中的增敏效益:機制解析、製劑開發與臨床轉譯洞察(1/3)
Lee, H.-L. (PI)
8/1/25 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
-
-
針對缺氧相關因子與緩激肽B1 受體-水通道蛋白4 訊號軸以克服多形性膠質母細胞瘤放射拮抗性之研究
Lee, H.-L. (PI)
1/1/22 → 12/31/22
研究計畫: B - 校內計畫 › h - 教育部-深耕計畫
-
-
Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation
Wu, M. S., Kao, W. Y., Chiang, M. F., Chuang, P. H., Hsu, S. J., Wang, S. Y., Chang, C. W., Lin, C. C., Hung, C. H., Wu, C. H., Chen, S. C., Lee, H. L., Hwang, J. I., Liang, P. C., Lin, S. M. & Wang, C. C., 2025, (接受/付印) 於: Liver Cancer.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯(Scopus) -
Correction: Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma (Biomedicines, (2023), 11, 7, (2081), 10.3390/biomedicines11072081)
Lee, H. L., Tsai, Y. C., Pikatan, N. W., Yeh, C. T., Yadav, V. K., Chen, M. Y. & Tsai, J. T., 9月 2025, 於: Biomedicines. 13, 9, 2271.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis
Peng, H. Y., Chang, K. Y., Chang, W. M., Wu, C. Y., Lee, H. L., Chang, Y. C., Liu, K. J., Shiah, S. G., Kuo, C. C. & Chang, J. Y., 8月 2025, 於: Neoplasia (United States). 66, 101193.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Health risk assessment for severe COVID-19 in Taiwan: a multi-centre electronic health record study
Chang, Y. H., Burton, W., Nguyen, P. A., Khang, D. D., Chen, C. I., Huang, C. C., Lam, C. S. K., Lin, W. K., Wang, F. D., Phuc, P. T., Lu, C. Y., Lee, H. L., Hsu, M. H., Huang, C. W., Yang, H. C., Lin, S. M., Yang, C. & Hsu, J. C., 2025, 於: Journal of Global Health. 15, 04236.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Neurofibromatosis Type 1: A General Review
Liao, M., Lee, H. L., Liu, Y. L. & Wong, T. T., 11月 2025, 於: Journal of Korean Neurosurgical Society. 68, 6, p. 644-651 8 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯(Scopus)
資料集
-
MOESM1 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, G.-M. (Contributor), Li, C.-H. (Contributor), Yeh, C.-F. (Creator), Whang-Peng, J. (Creator), Lee, H.-L. (Contributor), Yao, C.-J. (Contributor), Lai, I.-C. (Contributor), Chuang, S.-E. (Contributor), Chow, J.-M. (Contributor), Bai, K.-J. (Contributor) & Yan, J.-L. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d1.v1
資料集: Dataset
-
MOESM3 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Whang-Peng, J. (Creator), Chow, J.-M. (Contributor), Yan, J.-L. (Contributor), Lee, H.-L. (Contributor), Yeh, C.-F. (Creator), Lai, I.-C. (Contributor), Yao, C.-J. (Contributor), Lai, G.-M. (Contributor), Bai, K.-J. (Contributor), Chuang, S.-E. (Contributor) & Li, C.-H. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d3.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d3.v1
資料集: Dataset
-
Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer
Wen, Y.-C. (Creator), Lee, L.-M. (Creator), Lin, Y.-W. (Creator), Syu, S.-H. (Creator), Lin, K.-H. (Creator), Fan, Y.-C. (Creator), Lee, H.-L. (Creator), Lai, B. C. H. (Creator) & Shih, H.-J. (Creator), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.17009635.v1, https://tandf.figshare.com/articles/journal_contribution/Loco-regional_deep_hyperthermia_combined_with_intravesical_Mitomycin_instillation_reduces_the_recurrence_of_non-muscle_invasive_papillary_bladder_cancer/17009635/1
資料集: Dataset
-
MOESM2 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Chuang, S.-E. (Contributor), Lai, I.-C. (Contributor), Yeh, C.-F. (Creator), Yan, J.-L. (Contributor), Yao, C.-J. (Contributor), Whang-Peng, J. (Creator), Li, C.-H. (Contributor), Chow, J.-M. (Contributor), Bai, K.-J. (Contributor), Lee, H.-L. (Contributor) & Lai, G.-M. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d2.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d2.v1
資料集: Dataset
-
Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I.-C. (Contributor), Lai, G.-M. (Contributor), Chow, J.-M. (Contributor), Lee, H.-L. (Contributor), Yeh, C.-F. (Creator), Li, C.-H. (Contributor), Yan, J.-L. (Contributor), Chuang, S.-E. (Contributor), Whang-Peng, J. (Creator), Bai, K.-J. (Contributor) & Yao, C.-J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717.v1
資料集: Dataset